Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 74Burkitt Lymphoma 43Neoplasm, Residual 18Leukemia 16Recurrence 14Lymphoma, Non-Hodgkin 8Leukemia, Biphenotypic, Acute 8Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 6Lymphoproliferative Disorders 6Lymphatic Diseases 5Leukemia, Lymphoid 5Lymphoma, Large B-Cell, Diffuse 4Lymphoma, B-Cell 4Lymphoma 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Immunoproliferative Disorders 4Neoplasms 3Blast Crisis 3Myelodysplastic Syndromes 2Leukemia, Myelomonocytic, Juvenile 2Leukemia, Myeloid, Acute 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Myeloid 2Leukemia, Lymphocytic, Chronic, B-Cell 2Hematologic Neoplasms 2Down Syndrome 2Bites and Stings 2Sarcoma, Myeloid 1Philadelphia-Negative ALL 1Philadelphia Chromosome 1

Interventions

blinatumomab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Philadelphia-Negative ALL × blinatumomab × Clear all
NCT04334993 2021-05-07

Pediatric-type Therapy With Pre-transplant Blinatumomab for HR Patients - Phase II Study

Israeli Medical Association

Phase 2 Unknown
110 enrolled

Philadelphia-Negative ALL

Data powered by HemOnc (CC BY 4.0) Colophon âš¡